Related Experiment Video
Updated: Aug 8, 2025

Nephrotoxin Microinjection in Zebrafish to Model Acute Kidney Injury
Published on: July 17, 2016
Acute Kidney Injury Among Children Likely Associated with Diethylene Glycol-Contaminated Medications - The Gambia,
Insights
Contaminated syrup-based medications caused a severe acute kidney injury (AKI) outbreak in Gambian children. Health officials recalled the drugs and recommend enhanced surveillance to prevent future medication-related public health emergencies.
Area of Science:
- Public Health
- Epidemiology
- Pediatric Nephrology
Background:
- A cluster of acute kidney injury (AKI) cases in children was reported in The Gambia in July 2022.
- The Ministry of Health (MoH) requested assistance from the Centers for Disease Control and Prevention (CDC) to investigate the outbreak.
Purpose of the Study:
- To characterize the illness and epidemiology of the AKI outbreak.
- To identify potential causal factors and sources of the outbreak.
- To inform public health interventions and prevent future occurrences.
Main Methods:
- Review of medical records of affected children.
- Interviews with caregivers to identify exposures.
- Collaboration between The Gambia's MoH and CDC.
Main Results:
- Preliminary investigation implicated contaminated syrup-based children's medications as the likely cause of the AKI outbreak.
- The MoH recalled medications from a single international manufacturer.
- The outbreak highlighted vulnerabilities in pharmaceutical quality control and surveillance.
Conclusions:
- Strengthening pharmaceutical quality control is crucial.
- Enhancing event-based public health surveillance is necessary.
- Preventing future medication-related outbreaks requires a multi-faceted approach.
Abstract:
On July 26, 2022, a pediatric nephrologist alerted The Gambia's Ministry of Health (MoH) to a cluster of cases of acute kidney injury (AKI) among young children at the country's sole teaching hospital, and on August 23, 2022, MoH requested assistance from CDC. CDC epidemiologists arrived in The Gambia, a West African country, on September 16 to assist MoH in characterizing the illness, describing the epidemiology, and identifying potential causal factors and their sources. Investigators reviewed medical records and interviewed caregivers to characterize patients' symptoms and identify exposures. The preliminary investigation suggested that various contaminated syrup-based children's medications contributed to the AKI outbreak. During the investigation, MoH recalled implicated medications from a single international manufacturer. Continued efforts to strengthen pharmaceutical quality control and event-based public health surveillance are needed to help prevent future medication-related outbreaks.
Related Concept Videos
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury I: Introduction
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury VI: Nursing Management

